Pharmacology_ Principles, Administration, and Systemic Drug Actions

Understanding drug nomenclature is a fundamental aspect of medical coding and pharmacology, encompassing the various naming conventions and classifications of drugs. This knowledge is crucial for accurately identifying medications, understanding their purpose, and applying the correct codes for diagnoses, procedures, and related conditions.

Types of Drug Names

All drugs typically have three distinct names:

1. Chemical Name: This name is based on the drug’s molecular structure and is often complex. For example, N-(4-hydroxyphenyl) acetamide is the chemical name for acetaminophen.
2. Generic Name (International Nonproprietary Name - INN): This is a shortened version of the chemical name and is the drug’s official name once approved by the FDA. Generic names are most often used for medical record documentation and coding purposes. Examples include acetaminophen and naproxen.
3. Brand Name (Trade Name): This is the patented name chosen by the manufacturer and protected under copyright. Brand names are generally more familiar to the public, such as Tylenol for acetaminophen or Advil for ibuprofen. Sometimes, different brand names may refer to the same medication. When the generic or chemical name is not available, CMS may use the brand name to distinguish products.

If a specific drug’s brand name is not listed in coding references, an Internet search or drug reference book can help determine its generic name or drug category.

Drug Classification and Stem System

Drugs are often classified based on their therapeutic purpose, action, or the body system they affect. A significant way to quickly understand a drug’s class is through its stem, which acts like a root word. Suffixes also help define the drug class.

Examples of drug classes and their common stems include:

• ** -vir-**: Antiviral drugs (e.g., Acyclovir)
• ** -cillin**: Penicillin-derived antibiotics (e.g., Penicillin)
• ** -mab**, ** -ximab**, ** -zumab**: Monoclonal antibodies (e.g., Trastuzumab, Infliximab, Natalizumab, Bevacizumab)
• ** -tinib**: Tyrosine-kinase inhibitors (e.g., Erlotinib, Crizotinib)
• ** -prazole**: Proton-pump inhibitors (e.g., Omeprazole)
• ** -sartan**: Angiotensin receptor antagonists (e.g., Losartan, Valsartan)
• ** -olol**: Beta-blockers (e.g., Propranolol)
• ** -tidine**: H2 antagonists (e.g., Ranitidine)

Other broad categories include:

• Antibiotics: Destroy or inhibit bacterial growth (e.g., Penicillin V Potassium, Tetracycline, Amoxicillin, Cephalosporins, Ciprofloxacin, Metronidazole, Azithromycin).
• Antifungals: Inhibit or kill fungal growth (e.g., Griseofulvin, Ketoconazole, Clotrimazole, Fluconazole).
• Antivirals: Inhibit viral growth (e.g., Acyclovir, Zidovudine, Amantadine).
• Antiretrovirals: Treat retrovirus infections (e.g., NRTIs, NNRTIs, Protease inhibitors).
• Antiprotozoals: Inhibit protozoal infections (e.g., Chloroquine HCl).
• Antipyretics: Reduce fever (e.g., Acetaminophen, Acetylsalicylic acid, Ibuprofen).
• Antituberculars: Suppress mycobacterium causing tuberculosis.
• Antianginals: Used for chest pains.
• Antihypertensives: Lower blood pressure.
• Vasodilators: Dilate the vascular system (e.g., nitro patches/pills).
• ACE Inhibitors: A class of cardiovascular drugs.
• NSAIDs (Nonsteroidal Anti-inflammatory Drugs): Such as Naproxen.
• Antineoplastics: Used in cancer treatment. The ICD-10-PCS conversion table frequently mentions the specific designation of “Antineoplastic, Monoclonal Antibody”.

CMS generally creates HCPCS Level II codes for the products themselves, without specifying a route of administration in the code descriptor, as there might be multiple routes for the same product. Dose descriptors for HCPCS codes are assigned in the smallest amount that can be billed in multiple units to accommodate various doses and streamline billing.

Relevance to Medical Coding

A thorough understanding of drug nomenclature and pharmacology is vital for coders. It helps:

• Identify potential diagnoses: Medications a patient is on can indicate a list of possible diagnoses.
• Understand disease processes and treatments: Knowing drug actions and purposes is crucial for comprehending medical records.
• Abstract procedures: Knowledge of administration routes (e.g., topical, enteral, parenteral, intravenous, intramuscular, subcutaneous) helps code procedures accurately. The ICD-10-PCS includes a specific “Administration” section for putting substances into or onto the body. This section classifies root operations based on the broad category of substance administered, such as “Introduction” for therapeutic, diagnostic, nutritional, physiological, or prophylactic substances (except blood products), “Irrigation” for cleansing substances, and “Transfusion” for blood products. The 6th character substance value in the Administration section defines the blood component or other liquid substance.
• Differentiate between adverse effects, poisonings, and underdosing: These are critical distinctions in coding that directly impact code selection and often result in inpatient admissions.

The Table of Drugs and Chemicals (ICD-10-CM)

This table is an essential tool for coding adverse effects, poisonings, underdosing, and toxic effects. It lists substances and provides specific codes (from categories T36-T50) based on the nature of the event.

Key rules for using the Table of Drugs and Chemicals:

• Do not code directly from the table; always refer back to the Tabular List for verification.
• Use as many codes as necessary to describe all drugs and substances completely.
• If the same code describes the causative agent for more than one adverse reaction, poisoning, toxic effect, or underdosing, assign the code only once.
• If two or more drugs are involved, code each individually unless a combination code is listed in the table.
• For multiple unspecified drugs, use the appropriate code from subcategory T50.91.

Distinguishing Adverse Effects, Poisoning, and Underdosing

The intent and circumstances surrounding drug use are vital for accurate coding.

• Adverse Effect: Occurs when a drug or medicinal substance is taken correctly (as prescribed or per instructions), but the patient experiences a harmful or abnormal reaction (e.g., an allergic reaction). Coding an adverse effect typically requires at least two codes: one from categories T36-T50 to identify the drug and another to identify the manifestation (e.g., hematuria due to Coumadin).
• Poisoning: Involves a harmful effect caused by improper use of a medication, which could be due to the wrong dose, wrong medication, lack of knowledge, intentional self-harm, assault, or accidental ingestion. Poisonings and toxic effects are grouped under Major Diagnostic Category 21 in MS-DRG V42.0.
• Underdosing: Occurs when a patient takes less of a medication than prescribed or instructed, leading to an effect like a relapse of the condition the drug was intended to treat.

ICD-10-CM guidelines specify that if the provider documents “use,” “abuse,” and “dependence” for the same substance, only one code should be assigned based on a hierarchy: dependence takes precedence over abuse, and abuse takes precedence over use. Medical conditions due to psychoactive substance use, abuse, and dependence are not classified as substance-induced disorders; rather, the medical condition code is assigned along with the appropriate substance use, abuse, or dependence code (e.g., alcoholic pancreatitis with alcohol dependence).

Additionally, specific Z codes (e.g., Z79) are used to indicate long-term drug therapy for chronic conditions or prophylactic measures, but not for acute treatments. Z codes (e.g., Z88) are also used for allergy status to specific drugs.

Medical Abbreviations and Specialized Keys

Healthcare professionals use numerous abbreviations to save time in documentation. While many are common sense, some can be confusing (e.g., MS could mean morphine sulfate or magnesium sulfate) and are on a “Do Not Use” list to prevent errors. Coders must be familiar with common abbreviations for medication administration and dosages (e.g., IM, IV, p.o., tid, hs) to accurately interpret medical records.

The ICD-10-PCS also utilizes a Substance Key, which refers common substance names or manufacturer’s substance names to their corresponding ICD-10-PCS substance values. This helps coders translate clinical documentation into the precise terminology required by PCS. Notably, the substance values for anesthetic agents were revised to no longer specify the type of anesthetic, indicating a broader classification. Similarly, there have been clarifications in code titles to specify “antineoplastic, monoclonal antibody”.

Overall, a robust understanding of drug nomenclature is foundational for medical coders, enabling them to navigate complex medical documentation, apply correct codes, and ensure accurate reimbursement and patient care data.

Routes of administration in pharmacology refer to the path by which a drug or other substance is introduced into the body. This classification can be based on the application location or the target action of the drug. Understanding these routes is critical for healthcare professionals, including coders, as they directly impact treatment, patient safety, and accurate medical coding.

Pharmacology and Administration of Medication

Pharmacology is the study of drugs, including their actions, purpose, dosage, and administration. The administration of medication considers how the substance is introduced into the body, which varies based on factors like the drug’s properties and the desired effect. For instance, some medications cannot be taken orally because gastric juices would destroy their components, making intramuscular (IM) injection necessary, as with B12 shots.

The study of how drugs are administered and eliminated in the body is called pharmacokinetics, while pharmacodynamics focuses on how drugs affect the body.

Main Types of Administration Routes

Routes of administration are broadly categorized into three main types:

1. Topical (Local): Applied onto the skin or mucous membranes for local action. Examples include rubbing a substance onto the skin, allergy testing, or typical local anesthesia. This is also referred to as epicutaneous administration.
2. Enteral: Delivered through the gastrointestinal (GI) tract. This includes swallowing medications, or administration via the mouth (oral), or other parts of the GI tract such as suppositories (rectal).
3. Parenteral: Delivered system-wide through routes other than the GI tract. This typically involves injections.

Specific Routes of Administration

The sources list several specific routes of administration:

• Oral: Taken via the mouth.
• Epicutaneous: Application onto the skin. Examples include allergy testing or typical local anesthesia.
• Inhalational: Medication is inhaled using a machine or inhaler, commonly used for asthma medications.
• Enema: Medication inserted into the rectum. This is distinct from general rectal administration.
• Rectal: Via the rectum.
• Intravenous (IV): Directly into a vein. Used for fluids, antibiotics, and chemotherapy, and may require specific types of access (peripheral or central catheters, implanted port devices).
• Intra-arterial: Into an artery. Examples include vasodilator drugs for vasospasm or thrombolytic drugs for embolism treatment.
• Intraosseous infusion: Into the bone marrow, providing indirect intravenous access because bone marrow drains directly into the venous system. Used in emergency medicine and pediatrics when IV access is difficult.
• Intramuscular (IM): Into the muscle.
• Intracerebral: Into the brain parenchyma.
• Intracerebroventricular: Into the cerebral ventricular system.
• Subcutaneous: Under the skin.

ICD-10-PCS Administration Section (Section 3 )

The ICD-10-PCS (International Classification of Diseases, Tenth Revision, Procedure Coding System) includes a specific section for “Administration” procedures, designated as Section 3. This section is used for procedures involving “putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance”.

Structure of Administration Codes (Seven Characters):

1. Character 1: Section (always ‘3’ for Administration).
2. Character 2: Body System (identifies physiological systems and anatomical regions, circulatory system, or indwelling device).
3. Character 3: Root Operation (identifies the type of administration procedure).
4. Character 4: Body System/Region.
5. Character 5: Approach.
6. Character 6: Substance.
7. Character 7: Qualifier.

Root Operations in the Administration Section: The Administration section has three distinct root operations, classified based on the broad category of the substance administered:

• 0 - Introduction: Defined as “putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products”.
  • Examples: Nerve block injection to median nerve, introduction of anti-neoplastic substances, introduction of anti-inflammatory into peripheral vein, radioactive substances into subcutaneous tissue, or other diagnostic substances into the spinal canal.
• 1 - Irrigation: Defined as “putting in or on a cleansing substance”.
  • Examples: Flushing of eye, irrigation of an indwelling device.
• 2 - Transfusion: Defined as “putting in blood or blood products”.
  • Examples: Transfusion of cell saver red cells into central venous line, administration of nonautologous red blood cells via peripheral vein.

Key Considerations for Coding Administration Procedures:

• Substance Classification: The specific substance (Character 6 ) and qualifier (Character 7 ) are crucial for accurate coding in this section.
• Transplantation vs. Administration: Putting in a mature and functioning living body part from another individual or animal is coded to the root operation Transplantation. However, putting in autologous or nonautologous cells (e.g., bone marrow, pancreatic islet cells, stem cells) is coded to the Administration section.
• Irrigation of Indwelling Device: Irrigation of an indwelling device (e.g., percutaneous nephrostomy tube) is coded to the root operation Irrigation in the Administration section.

Example of an Administration Code (RBCs via peripheral vein):

• 3 (Administration Section)
• 0 (Circulatory Body System)
• 2 (Transfusion Root Operation)
• 3 (Peripheral Vein Body System/Region)
• 3 (Percutaneous Approach)
• N (Red Blood Cells Substance)
• 1 (Nonautologous Qualifier)

Documentation Standards for Medication Administration

CMS (Centers for Medicare & Medicaid Services) has detailed Conditions of Participation (CoP) that hospitals must adhere to regarding medication administration. These standards ensure patient safety and accurate record-keeping.

Hospital Policies and Procedures: Hospitals’ medical staff must approve policies and procedures for medication administration, often in consultation with nurses, pharmacists, and quality improvement staff. These policies should cover:

• Personnel Authorization: Identifying licensed personnel and other staff authorized to administer medications, consistent with state laws and scope-of-practice.
• Education and Training: Training for all personnel administering drugs and biologicals, typically included in orientation or continuing education.
• Order Requirements: Drugs must be administered in response to an order from a practitioner or based on a standing order, which must be authenticated. Required elements of an order include date, time, drug name, dose, frequency, route, dose calculation requirements, strength, quantity/duration, specific instructions, and prescriber’s name.
• Timeliness: Policies must address the timing of medication administration to ensure safety and effectiveness, differentiating between medications eligible and not eligible for scheduled dosing times (e.g., STAT doses, one-time doses, time-sequenced doses).
• Patient Monitoring: Patients must be carefully monitored for therapeutic effects and adverse reactions. This includes assessing risk factors (age, organ function, weight, drug interactions) and communicating relevant information during hand-offs.
• Reporting Adverse Events: A hospital procedure is required for reporting transfusion reactions, adverse drug reactions (ADRs), and errors in administration. These events must be immediately reported to the attending physician and, if appropriate, to the hospital’s Quality Assessment and Performance Improvement (QAPI) program.

Verbal Orders:

• Infrequent Use: Verbal orders should be used infrequently due to the increased risk of miscommunication. They are only for situations where it’s impossible or impractical for the practitioner to write or enter the order electronically without delaying treatment, not for convenience.
• Read-back Verification: CMS expects nationally accepted read-back verification practices for every verbal order.
• Prompt Documentation and Authentication: Verbal orders must be promptly documented by the receiver and authenticated as soon as possible by the ordering practitioner. If the ordering practitioner is unavailable, another practitioner responsible for the patient’s care may authenticate, if permitted by state law and hospital policy.

Standing Orders and Protocols: Hospitals may use standing orders, order sets, and protocols if they are reviewed and approved by medical staff, nursing, and pharmacy leadership. These protocols must include evidence-based national guidelines, staff training, and periodic evaluation.

Patient Self-Administration: Hospitals have the option to establish programs for patient self-administration of hospital-issued medications, or by caregivers/support persons. Such programs require clear policies and procedures, including an order for self-administration, nurse assessment of the patient’s capacity, instruction in safe techniques, and documentation of self-administration times and doses.

Documentation of Administration: Documentation of medication administration is addressed in the Medical Records CoP. It must occur after the actual administration to the patient; advance documentation is inappropriate and can lead to errors. The record must contain all practitioners’ orders, nursing notes, reports of treatment, medication records, and other information necessary to monitor the patient’s condition.

In summary, routes of administration are fundamental to pharmacology and healthcare delivery. Standards for documentation and coding, particularly under ICD-10-PCS and CMS regulations, ensure that these procedures are accurately recorded, support patient care, and facilitate appropriate reimbursement and compliance.

Medical records are crucial for documenting a patient’s health history and care, and a significant part of this documentation involves the use of medications to treat various system disorders. Understanding pharmacology—the study of drugs, their actions, dosages, administration, therapeutic uses, and adverse effects—is fundamental for proper medical coding and patient care.

General Principles of Pharmacology and Drug Use

Drugs are identified by several names: a chemical name (based on molecular structure), an international nonproprietary name (INN) or generic name (approved by the FDA as the official name), and a brand or trade name (patented by the manufacturer). Dosage is a critical consideration, varying based on factors such as age and weight.

Medications can be administered through different routes:

• Enteral administration involves the gastrointestinal (GI) tract, such as swallowing a pill or using suppositories.
• Parenteral administration involves routes other than the GI tract, such as injections (intramuscular, intravenous, intra-arterial, intraosseous, intracerebral, intracerebroventricular).
• Topical administration is for local action.

The study of how the body administers and eliminates drugs is called pharmacokinetics, while pharmacodynamics focuses on how drugs affect the body.

Adverse Effects, Poisonings, and Underdosing

It is crucial to distinguish between adverse effects, poisonings, and underdosing, as these are coded differently and have distinct clinical implications.

• Adverse effect occurs when a patient experiences a harmful or abnormal reaction to a medication taken as prescribed, for the correct diagnosis, and administered correctly. Examples include allergic reactions to penicillin or drug-induced conditions like systemic lupus erythematosus. When coding an adverse effect, at least two codes are required: one from categories T36-T50 (with a fifth or sixth character ‘5’) to identify the drug, and additional codes for the manifestations.
• Poisoning involves a harmful effect from the improper use of medication. This can include taking the wrong medication, the wrong dose (e.g., double the dosage or an overdose), or interactions with non-prescribed or illegal drugs and alcohol. Poisoning can also occur if the drug is administered to purposely harm oneself or by another person, even if accidental. Drug toxicity is classified as poisoning when a nonprescribed drug interacts with a correctly administered drug, or when a drug interacts with alcohol. Drug-induced conditions due to poisoning may require a code from T36-T65 (with fifth or sixth character 1-4).
• Underdosing occurs when a patient takes less medication than prescribed by a provider or manufacturer, or discontinues a prescribed medication on their own initiative. Documentation of a change in the patient’s condition is not required for underdosing codes (T36-T50 with fifth or sixth character ‘6’).

Long-Term Drug Therapy

For continuous use of a prescribed drug for long-term treatment of a chronic condition or for prophylactic use, Z codes from category Z79 (Long-term (current) drug therapy) are assigned. These codes are not used for patients with drug addictions or for medications administered for a brief period or acute illnesses. Examples include Z79.01 for long-term anticoagulant use and Z79.52 for long-term systemic steroids.

Specific Medication Categories for System Disorders

Cardiovascular System Disorders

Drugs for cardiovascular disorders aim to manage heart function, blood pressure, and blood flow.

• Antianginals are used for chest pain.
• Antihypertensives lower blood pressure and include ACE inhibitors (e.g., enalapril, lisinopril, ramipril), beta-blockers (e.g., propranolol, atenolol, Vasotec, Cozaar, Calan, Cardizem, Aldomet), and diuretics.
• Vasodilators (e.g., nitroglycerin patches) dilate the vascular system.
• Vasoconstrictors increase blood pressure and are used for hypotension.
• Diuretics (e.g., Lasix, Bumex, Zaroxolyn, Furosemide, Esidrix, HCTZ) help the body shed fluid.
• Anticoagulants (e.g., Coumadin/warfarin, heparin, Plavix, Ticlid) treat or prevent blood clots (thrombosis) and embolisms. They are used for conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism, and as a preventive measure for patients with artificial heart valves, coronary artery stents, or a history of TIAs. Warfarin dosing requires close monitoring due to interactions with other medications and foods.
• Clot-busting agents such as tPA and streptokinase are also used for stroke/CVA (nonhemorrhagic).
• Antiarrhythmics affect the heart’s rhythm.
• Antihyperlipidemic and antiarteriosclerotic drugs are also used.

Endocrine System Disorders

The endocrine system’s wide range of functions necessitates diverse medications.

• Corticosteroids (e.g., cortisone, prednisolone, methylprednisolone, dexamethasone, hydrocortisone) are frequently used to reduce inflammation and swelling. They can also serve as replacement therapy for conditions like Addison’s disease. Long-term use can lead to side effects such as bruising, weight gain, increased blood pressure, and osteoporosis.
• Diabetes mellitus drugs include insulin and oral medications like biguanides and sulfonylureas to manage blood glucose levels.
• Lipid-lowering drugs such as statins, fibrates, nicotinic acid, bile salt binders, and omega-3s reduce fat in the bloodstream.
• Thyroid medications are used for hypo- and hyperthyroidism.

Gastrointestinal System Disorders

Medications for the GI tract primarily address issues related to stomach acid, ulcers, and inflammation.

• Acid-reducing medications (e.g., omeprazole/Prilosec, famotidine, pantoprazole, lansoprazole/Prevacid, Pepcid, Axid, Nexium) are used for heartburn, gastric issues, and ulcers.
• Antiemetics (e.g., Promethazine, prochlorperazine, ondansetron) reduce nausea and vomiting.
• Antidiarrheals (e.g., diphenoxylate atropine, loperamide hydrochloride) manage diarrhea.
• Specific medications for conditions like diverticulitis (metronidazole, ciprofloxacin) and Crohn’s disease (adalimumab) are also used.

Respiratory System Disorders

Respiratory medications often aim to improve airflow and manage symptoms.

• Bronchodilators (e.g., sympathomimetics like Proventil and Ventolin; anticholinergics; xanthenes) relax airway muscles, opening the bronchial passages. They are used for asthma, COPD, and emphysema.
• Antitussives (cough suppressants) and expectorants are also used.

Musculoskeletal System Disorders

These drugs address pain, inflammation, and muscle function.

• Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, diclofenac, etodolac, naproxen, meloxicam) are nonopioid painkillers that reduce discomfort and inflammation from various musculoskeletal conditions.
• Antirheumatic drugs (e.g., methotrexate, ciclosporin, infliximab, rituximab) treat autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus by altering immune system activity.
• Muscle relaxants (e.g., diazepam/Valium, metaxalone/Skelaxin, carisoprodol/Soma) relieve muscle spasms and improve movement in nervous system disorders.
• Analgesics (e.g., hydromorphone HCl, hydrocodone w/APAP, tramadol, oxycodone) block pain signals, with stronger options for severe pain.
• Specific therapeutic substances can be introduced into joints, such as ZYNRELEF® (bupivacaine and meloxicam) for postsurgical analgesia.

Nervous System Disorders

Medications target conditions ranging from neurodegenerative diseases to mental health issues and substance abuse.

• Drugs for neurodegenerative diseases like Alzheimer’s (e.g., solanezumab) focus on protein-related pathologies.
• Antiepileptic/anticonvulsant drugs (e.g., phenytoin/Dilantin, carbamazepine/Tegretol, divalproex sodium/Depakote, sodium valproate, valproic acid) treat seizures.
• Antiparkinsonism drugs.
• Psychiatric medications include antipsychotics (e.g., haloperidol, chlorpromazine), antidepressants (e.g., fluoxetine, sertraline), and antianxiety drugs.
• ADD/ADHD medications include stimulants like methylphenidate (Ritalin, Concerta) and amphetamine dextroamphetamine (Adderall).
• Medications for alcohol withdrawal involve benzodiazepines (e.g., diazepam, chlordiazepoxide), beta-blockers (e.g., propranolol, atenolol), and antiseizure medications.
• Pharmacotherapy for substance abuse includes replacement medications (e.g., nicotine replacement, methadone, levo-alpha-acetyl-methadol (LAAM)), and other agents like Antabuse, naltrexone, naloxone, clonidine, and bupropion. Psychiatric medications are also used in this context.

Infectious and Parasitic Diseases

Antimicrobial drugs target specific types of pathogens.

• Antibiotics (e.g., penicillins, cephalosporins, tetracyclines, macrolides like azithromycin) destroy or inhibit bacterial growth and are commonly used for short-term minor infections like ear, throat, or urinary tract infections, as well as serious infections like septicemia and bacterial meningitis.
• Antifungals inhibit or kill fungal growth.
• Antivirals inhibit viral growth, while antiretrovirals specifically treat retroviral infections.
• Antiprotozoals inhibit protozoal infections, and antitubercular drugs suppress mycobacterium causing tuberculosis.

Genitourinary System Disorders

Medications include antibiotics for infections like UTIs and PID, as well as drugs for conditions such as benign prostatic hypertrophy and incontinence.

Pregnancy, Childbirth, and Puerperium

Certain drugs are used during pregnancy and childbirth, such as oxytocic drugs (e.g., pitocin, terbutaline) for labor induction, and analgesics (e.g., meperidine, stadol, butorphanol, spinal anesthesia) for pain management. Drug use complicating pregnancy is coded under O99.32.

Patient Safety and Monitoring

Drugs can cause various adverse reactions, and certain types of medications, often referred to as “high-alert” medications (e.g., opioids), pose a heightened risk of significant patient harm when used in error. Hospitals must have policies and procedures for the safe administration and monitoring of drugs, including assessing patient risk factors (e.g., age, organ function, weight, other medications), and conducting timely interventions for adverse events like respiratory depression from opioids. Documentation of medication administration and its outcomes is essential for future care planning and to prevent errors. Verbal orders for drugs must be authenticated, and pre-printed orders should be approved and regularly reviewed.

Drugs are integral to the treatment of various system disorders, but their use comes with potential “side effects,” a term that encompasses a range of reactions, from minor discomforts to severe complications. In medical documentation and coding, it’s crucial to distinguish between “adverse effects,” “poisonings,” and “underdosing,” as these terms have specific definitions and coding implications.

Adverse Effects of Drugs

An adverse effect occurs when a patient experiences a harmful or abnormal reaction to a medication that has been correctly prescribed, for the appropriate diagnosis, and administered properly. This means the drug was taken as intended, but the body reacted negatively. Examples include allergic reactions, such as developing hives from Bactrim used for a UTI, or diarrhea from erythromycin for bronchitis. Other examples of the nature of an adverse effect include tachycardia, delirium, gastrointestinal hemorrhaging, vomiting, hypokalemia, renal failure, or respiratory failure. Drug-induced conditions, like systemic lupus erythematosus or certain types of diabetes mellitus, can also be classified as adverse effects if the medication was correctly administered.

Coding Adverse Effects: When coding an adverse effect, at least two codes are required:

1. An appropriate code for the nature of the adverse effect (the manifestation).
2. A code from categories T36-T50 to identify the drug responsible, with a fifth or sixth character ‘5’. The “Table of Drugs and Chemicals” is used to identify the specific T-code for the drug or drug category.

Examples of drugs that can cause adverse effects, and their corresponding T-codes, include:

• Macrolides (T36.3X5A).
• Rifampicins (T36.6X5A).
• Sulfonamides (T37.0X5A).
• Antimycobacterial drugs (T37.1X5A).
• Antimalarials and drugs acting on other blood protozoa (T37.2X5A).
• Other antiprotozoal drugs (T37.3X5A).
• Anthelminthics (T37.4X5A).
• Antiviral drugs (T37.5X5A).
• Glucocorticoids and synthetic analogues (T38.0X5A).
• Thyroid hormones and substitutes (T38.1X5A).
• Antithyroid drugs (T38.2X5A).
• Insulin and oral hypoglycemic drugs (T38.3X5A).
• Oral contraceptives (T38.4X5A).
• Other estrogens and progestogens (T38.5X5A).
• Androgens and anabolic congeners (T38.7X5A).
• Unspecified hormones and synthetic substitutes (T38.805A).
• Aspirin (T39.015A).
• Other salicylates (T39.095A).
• 4-Aminophenol derivatives (T39.1X5A).
• Pyrazolone derivatives (T39.2X5A).
• Propionic acid derivatives (T39.315A).
• Other nonsteroidal anti-inflammatory drugs [NSAID ] (T39.395A).
• Antirheumatics, NEC (T39.4X5A).
• Other nonopioid analgesics and antipyretics (T39.8X5A).
• Unspecified nonopioid analgesic, antipyretic and antirheumatic (T39.95XA).
• Opium (T40.0X5A).
• Other opioids (T40.2X5A).
• Methadone (T40.3X5A).
• Fentanyl or fentanyl analogs (T40.415A).
• Tramadol (T40.425A).
• Synthetic cannabinoids (T40.725A).
• Inhaled anesthetics (T41.0X5A).
• Intravenous anesthetics (T41.1X5A).
• Unspecified general anesthetics (T41.205A).
• Local anesthetics (T41.3X5A).
• Unspecified anesthetic (T41.45XA).
• Therapeutic gases (T41.5X5A).
• Hydantoin derivatives (T42.0X5A).
• Iminostilbenes (T42.1X5A).
• Succinimides and oxazolidinediones (T42.2X5A).
• Barbiturates (T42.3X5A).
• Benzodiazepines (T42.4X5A).
• Mixed antiepileptics (T42.5X5A).
• Other antiepileptic and sedative-hypnotic drugs (T42.6X5A).
• Antiparkinsonism drugs and other central muscle-tone depressants (T42.8X5A).
• Tricyclic antidepressants (T43.015A).
• Selective serotonin and norepinephrine reuptake inhibitors (T43.215A).
• Selective serotonin reuptake inhibitors (T43.225A).
• Other antidepressants (T43.295A).
• Phenothiazine antipsychotics and neuroleptics (T43.3X5A).
• Butyrophenone and thiothixene neuroleptics (T43.4X5A).
• Unspecified antipsychotics and neuroleptics (T43.505A).
• Methylphenidate (T43.635A).
• Other psychotropic drugs (T43.8X5A).
• Unspecified psychotropic drug (T43.95XA).
• Other parasympathomimetics [cholinergics ] (T44.1X5A).
• Ganglionic blocking drugs (T44.2X5A).
• Other parasympatholytics [anticholinergics and antimuscarinics ] and spasmolytics (T44.3X5A).
• Centrally-acting and adrenergic-neuron-blocking agents (T44.8X5A).
• Unspecified drugs primarily affecting the autonomic nervous system (T44.905A).
• Antiallergic and antiemetic drugs (T45.0X5A).
• Antineoplastic and immunosuppressive drugs (T45.1X5A).
• Vitamins (T45.2X5A).
• Anticoagulants (T45.515A).
• Antithrombotic drugs (T45.525A).
• Immunostimulant drugs (T45.AX5D).
• Angiotensin-converting-enzyme inhibitors (T46.4X5A).
• Other antihypertensive drugs (T46.5X5A).
• Antihyperlipidemic and antiarteriosclerotic drugs (T46.6X5A).
• Peripheral vasodilators (T46.7X5A).
• Antacids and anti-gastric-secretion drugs (T47.1X5A).
• Digestants (T47.5X5A).
• Antidiarrheal drugs (T47.6X5A).
• Emetics (T47.7X5A).
• Oxytocic drugs (T48.0X5A).
• Skeletal muscle relaxants [neuromuscular blocking agents ] (T48.1X5A).
• Other drugs acting on muscles (T48.295A).
• Antitussives (T48.3X5A).
• Expectorants (T48.4X5A).
• Antiasthmatics (T48.6X5A).
• Local antifungal, anti-infective and anti-inflammatory drugs (T49.0X5A).
• Keratolytics, keratoplastics, and other hair treatment drugs and preparations (T49.4X5A).
• Otorhinolaryngological drugs and preparations (T49.6X5A).
• Dental drugs, topically applied (T49.7X5A).
• Other topical agents (T49.8X5A).
• Mineralocorticoids and their antagonists (T50.0X5A).
• Loop [high-ceiling ] diuretics (T50.1X5A).
• Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics (T50.2X5A).
• Electrolytic, caloric and water-balance agents (T50.3X5A).
• Drugs affecting uric acid metabolism (T50.4X5A).
• Multiple unspecified drugs, medicaments and biological substances (T50.915A).

Many adverse effects require careful monitoring, especially with “high-alert” medications like opioids, which carry a heightened risk of harm. Patient-specific factors such as age, organ function, weight, and concurrent medications can increase the risk of adverse reactions.

Specific Drug Categories and Their Side Effects

Cardiovascular System Disorder Drugs:

• Diuretics (e.g., Lasix, Zaroxolyn): Common side effects include frequent urination, arrhythmia, electrolyte imbalance, muscle cramps, weakness, dizziness, blurred vision, and dehydration. Noncompliance with medications like Lasix can lead to conditions like CHF exacerbation.
• Anticoagulants (e.g., warfarin/Coumadin): Treat or prevent blood clots, but common complications include gastrointestinal bleeding, nosebleeds (epistaxis), blood in urine (hematuria), or hemorrhage from any tissue. Warfarin dosing requires close monitoring due to interactions with other medications and foods to avoid dangerous bleeding.
• ACE Inhibitors (e.g., enalapril, lisinopril): Primarily treat hypertension and congestive heart failure.
• Vasodilators (e.g., nitroglycerin patches): Dilate the vascular system.
• Vasoconstrictors: Increase blood pressure and are used for hypotension.
• Beta-blockers (e.g., propranolol/Inderal): Can cause dizziness and irregular heartbeat.

Endocrine System Disorder Drugs:

• Corticosteroids (e.g., cortisone, prednisolone, dexamethasone, hydrocortisone): Short-term use rarely causes side effects. Long-term use can lead to bruising, weight gain, increased blood pressure, and osteoporosis. Abrupt withdrawal from high-dose, long-term corticosteroids can cause a rapid fall in blood pressure and potentially fatal shock.
• Antithyroid Drugs (e.g., Carbimazole): Side effects are usually minor, including nausea, headache, rashes, itching, and joint pains. A rare but serious side effect is reduced white blood cell production, leading to neutropenia and agranulocytosis.
• Lipid-Lowering Drugs:
  • Statins (e.g., Lipitor, Zocor): Reduce cholesterol and triglycerides, but can cause nausea, headaches, abdominal pain, diarrhea or constipation. Long-term use may affect liver function.
  • Fibrates (e.g., Lopid, Tricor): Lower cholesterol and triglycerides; potential side effects include muscle pain, nausea, headache, and erectile dysfunction. Not suitable for patients with kidney, liver, or gallbladder disorders.
  • Nicotinic Acid and Derivatives: May cause facial flushing, unsteadiness, headache, nausea, vomiting, and itching, typically used when other drugs are ineffective.
  • Bile Salt Binders: Reduce fat absorption and lower cholesterol, possibly causing nausea, abdominal discomfort, and constipation. Long-term use may necessitate vitamin K supplements due to reduced absorption.
  • Ezetimibe (Zetia): Can cause gastrointestinal disturbances, headache, tiredness, and muscle pain.
  • Omega-3 Compounds: May cause gastrointestinal disturbances.

Gastrointestinal System Disorder Drugs:

• Acid-reducing medications (e.g., omeprazole/Prilosec, famotidine, pantoprazole, lansoprazole/Prevacid, ranitidine): Used for heartburn, gastric issues, and ulcers.
• Antidiarrheal drugs (e.g., Carbo medicinalis): Can be associated with adverse effects.

Respiratory System Disorder Drugs:

• Bronchodilators:
  • Sympathomimetics (e.g., Proventil, Ventolin): Relax airway muscles, but can cause slight tremor, agitation, insomnia, and rarely, a rapid heartbeat.
  • Anticholinergics (e.g., Atrovent, Spiriva): Often used with sympathomimetics for COPD; may cause dry mouth, difficulty urinating, blurred vision, and rarely, acute glaucoma.
  • Xanthines (e.g., Theophylline): Widen airways, with potential side effects including nausea and headaches. High doses can lead to rapid and irregular heartbeats.
• Antitussives (e.g., Carbetapentane): Can have adverse effects.
• Expectorants (e.g., Carbocisteine): Can have adverse effects.

Musculoskeletal System Disorder Drugs:

• Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, diclofenac, etodolac, naproxen, proquazone): Nonopioid painkillers that can irritate the stomach lining, causing nausea, indigestion, stomach bleeding, and peptic ulcers. High-dose, long-term use of some NSAIDs may increase the risk of heart disease and stroke. Allergic reactions like rashes and angioedema are also possible.
• Antirheumatic Drugs (e.g., methotrexate, ciclosporin, infliximab, rituximab): Treat autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus by altering immune system activity. These drugs are diverse and can cause a wide range of side effects, occasionally serious issues affecting the kidneys, liver, blood, or eyes.
• Muscle Relaxants (e.g., diazepam/Valium, metaxalone/Skelaxin, carisoprodol/Soma, carbolonium, suxamethonium): Relieve muscle spasms. Drowsiness is a common side effect, and long-term use can lead to dependence, with muscle spasms worsening if the drug is suddenly withdrawn.
• Analgesics (e.g., hydromorphone HCl, hydrocodone w/APAP, tramadol, oxycodone, propoxyphene): Block pain signals. Common adverse effects include nausea, vomiting, drowsiness, dry mouth, pupil contraction, low blood pressure, urinary retention, and constipation.

Nervous System Disorder Drugs:

• Antiepileptic/Anticonvulsant drugs (e.g., phenytoin/Dilantin, carbamazepine/Tegretol, divalproex sodium/Depakote, sodium valproate, valproic acid): Treat seizures. A patient presented with worsening twitching after starting neurontin for headaches.
• Drugs for neurodegenerative diseases (e.g., solanezumab for Alzheimer’s).
• Sedative, hypnotic, or anxiolytic drugs: Abuse or dependence can lead to various mental and behavioral disorders, including mood disorder, psychotic disorder (with delusions or hallucinations), anxiety disorder, sexual dysfunction, sleep disorder, persisting amnestic disorder, or persisting dementia.
• Neuroleptics/Antipsychotics: Can induce conditions like malignant neuroleptic syndrome, drug-induced parkinsonism, tardive dyskinesia, and acute dystonia.
• Psychotropic drugs (e.g., Zoloft): Can cause decreased sex drive.

Infectious and Parasitic Diseases Drugs:

• Antibiotics (e.g., penicillins, cephalosporins, tetracyclines, macrolides like azithromycin): Destroy or inhibit bacterial growth. They can cause antibiotic-associated diarrhea, such as pseudomembranous colitis.
• Antifungals (e.g., nystatin, fluconazole, clotrimazole): Topical antifungals usually have no side effects beyond irritation. Potent oral antifungals can cause nausea and vomiting, and rarely, kidney damage and blood disorders.
• Antivirals (e.g., acyclovir): Treat viral infections, often reducing severity rather than eliminating the infection.

Antineoplastic and Immunosuppressive Drugs:

• Cytotoxic drugs: Can cause severe side effects because they affect rapidly dividing cells throughout the body, including bone marrow, hair follicles, and the lining of the mouth and intestines. This can lead to reduced platelets, red blood cells, and white blood cells (anemia, increased infection susceptibility, reduced clotting ability), and folic acid deficiency. Nausea and vomiting are also common. Extravasation (leakage into surrounding tissue) of chemotherapeutic irritants (e.g., bleomycin, carboplatin) or vesicants (e.g., doxorubicin, paclitaxel) can cause significant damage or tissue necrosis.
• Immunosuppressive or immunomodulatory agents: Can have adverse effects, medication interactions, and potential complications. Immunodeficiency due to current or past medication use is documented.

Other Drug-Induced Conditions:

• Diabetes mellitus: Secondary diabetes can be caused by adverse effects of correctly administered medications.
• Dermatitis: Skin eruptions can occur due to drugs taken internally (e.g., categories L27.0, L27.1, L27.2, L27.8, L27.9), requiring a T36-T65 code to identify the drug.
• Gout: Drug-induced gout (M10.2) can occur at various sites.
• Movement Disorders: Drug-induced subacute dyskinesia, acute dystonia, tremor, chorea, tics, and other movement disorders (G24.01, G24.02, G24.09, G25.1, G25.4, G25.61, G25.70, G25.71, G25.79) are recognized conditions.
• Osteonecrosis: Drugs can cause osteonecrosis in various bones, including the shoulder, humerus, radius, ulna, carpus, hand, fingers, pelvis, and femur (M87.1).
• Osteoporosis: Other osteoporosis with current pathological fracture can be attributed to drugs (M80.80).
• Polyneuropathy: Drug-induced polyneuropathy (G62.0) is a recognized condition.
• Oral mucositis: Oral mucositis (ulcerative) due to other drugs (K12.32) is documented.

Poisoning

Poisoning differs from an adverse effect in that it results from the improper use of medication. This can include:

• Taking the wrong medication.
• Taking the wrong dose (e.g., double the prescribed dosage or an overdose).
• Interactions with non-prescribed drugs (including illegal drugs and alcohol).
• A drug being administered to purposely harm oneself or by another person, even if accidental.
• Drug toxicity is also classified as poisoning if a nonprescribed drug interacts with a correctly administered drug, or when a drug interacts with alcohol. Toxic doses of acetaminophen, for instance, can cause irreversible and fatal liver damage. Examples of substances causing toxic effects also include xylazine.

Coding Poisoning: When coding poisoning, the toxic effect code (from categories T36-T65, with a fifth or sixth character 1-4 to indicate the intent: accidental, intentional self-harm, assault, or undetermined) is assigned first, followed by codes for all associated manifestations of the toxic effect. The “Table of Drugs and Chemicals” also provides specific codes for poisonings by various substances.

Underdosing

Underdosing occurs when a patient takes less medication than prescribed by a provider or manufacturer, or discontinues a prescribed medication on their own initiative. It signifies that the patient did not adhere to the prescribed regimen.

Coding Underdosing: Underdosing is coded using categories T36-T50 with a fifth or sixth character ‘6’. Z codes, such as Z91.12- for noncompliance, can be used to indicate the intent if known.

Examples of underdosing for various drug categories include:

• Macrolides (T36.3X6A).
• Rifampicins (T36.6X6A).
• Sulfonamides (T37.0X6A).
• Immunostimulant drugs (T45.AX6D).
• Angiotensin-converting-enzyme inhibitors (T46.4X6A).
• Antihypertensive drugs (T46.5X6A).
• Antihyperlipidemic and antiarteriosclerotic drugs (T46.6X6A).
• Peripheral vasodilators (T46.7X6A).
• Antacids and anti-gastric-secretion drugs (T47.1X6A).
• Antidiarrheal drugs (T47.6X6A).
• Emetics (T47.7X6A).
• Oxytocic drugs (T48.0X6A).
• Skeletal muscle relaxants (T48.1X6A).
• Other drugs acting on muscles (T48.296A).
• Antitussives (T48.3X6A).
• Expectorants (T48.4X6A).
• Antiasthmatics (T48.6X6A).
• Local antifungal, anti-infective and anti-inflammatory drugs (T49.0X6A).
• Keratolytics, keratoplastics, and other hair treatment drugs and preparations (T49.4X6A).
• Otorhinolaryngological drugs and preparations (T49.6X6A).
• Dental drugs, topically applied (T49.7X6A).
• Other topical agents (T49.8X6A).
• Mineralocorticoids and their antagonists (T50.0X6A).
• Loop diuretics (T50.1X6A).
• Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics (T50.2X6A).
• Electrolytic, caloric and water-balance agents (T50.3X6A).
• Drugs affecting uric acid metabolism (T50.4X6A).
• Multiple unspecified drugs, medicaments and biological substances (T50.916A).

Patient Safety and Monitoring

Given the potential for drug side effects, robust patient safety measures are essential. This includes meticulous documentation of all medications, dosages, times, and routes of administration. Healthcare professionals should also note drug allergies, over-the-counter medications, and herbal remedies, as these can interact with prescribed drugs and cause harm.

Hospitals are required to have policies and procedures for safe medication administration and monitoring, particularly for “high-alert” medications. This includes assessing patient risk factors (e.g., age, organ function, weight, other medications), monitoring vital signs, pain, and sedation levels, and timely intervention for adverse events like respiratory depression from opioids. The patient’s perception of side effects and efficacy should also be considered. All relevant information regarding medication risks and monitoring must be communicated during patient hand-offs.

Drug classes are a fundamental concept in medical coding and healthcare, referring to the categorization of medications based on their chemical structure, mechanism of action, therapeutic use, or the body system they affect. A thorough understanding of pharmacology, including drug classes, actions, dosages, and administration, is crucial for healthcare professionals, especially for accurate medical coding.

I. Fundamentals of Pharmacology and Drug Nomenclature

Pharmacology is the study of drugs, encompassing their actions, purpose, dosage, administration, therapeutic uses, and potential adverse effects. This knowledge helps identify chronic illnesses documented in health records and assign correct codes.

Drugs typically have three names:

• Chemical Name: Based on the drug’s molecular structure. For example, N-(4-hydroxyphenyl) acetamide is the chemical name for acetaminophen.
• Generic Name (International Nonproprietary Name - INN): A shortened version of the chemical name, approved by the FDA, and often used for medical record documentation and coding. Ibuprofen is a generic name.
• Brand Name: The patented name selected by the manufacturer, such as Tylenol for acetaminophen or Advil for ibuprofen.

The stem (root word) and suffixes of a generic drug name often provide insight into its therapeutic purpose and drug class. For example, “-vir-” indicates an antiviral drug (e.g., Acyclovir), “-cillin” indicates a penicillin-derived antibiotic (e.g., Penicillin), and “-prazole” indicates a proton-pump inhibitor (e.g., Omeprazole).

II. Drug Administration Routes

Medications can be administered through various routes, broadly categorized into three main types:

• Topical (Local): Applied directly to the skin or mucous membranes for local absorption or effect, such as medicated patches or ointments. Examples include epicutaneous applications, eye drops, ear drops, or creams.
• Enteral: Delivered via the gastrointestinal (GI) tract. This includes oral ingestion (swallowed tablets, capsules, drops), or administration through feeding tubes (gastric, duodenal, gastrostomy), or rectally (suppositories, enemas).
• Parenteral: Any route other than the GI tract, usually involving injections or infusions for systemic effect. Examples include intravenous (IV), intramuscular (IM), intra-arterial, intraosseous infusion, subcutaneous, intracerebral, or intrathecal. Intravenous medications and blood transfusions must be administered according to state law and approved medical staff policies.

For coding purposes in ICD-10-PCS (Procedure Coding System), the “Administration” section (Section 3 ) classifies procedures based on the broad category of the substance administered. Root operations in this section include:

• Introduction: For putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance, except blood or blood products.
• Irrigation: For putting in or on a cleansing substance.
• Transfusion: For putting in blood or blood products.

Substances administered are further specified in character 6 of the PCS code, for example, Antineoplastic, Anti-infective, Anti-inflammatory, Hormones, Immunotherapeutic agents, Analgesics, Hypnotics, Sedatives, Radioactive Substances, and more. Newer substances are often introduced under “New Technology” codes (e.g., Xanomeline and Trospium Chloride, Paclitaxel-Coated Balloon Technology).

III. Adverse Effects vs. Poisoning

A critical distinction for coding is between an adverse effect and poisoning.

• Adverse Effect: Occurs when a patient takes a medication as prescribed, but the body reacts negatively or something goes wrong. This includes allergic reactions to drugs or other unintended side effects. For example, being allergic to penicillin and breaking out in spots after taking it.
• Poisoning: Involves harmful effects caused by improper use of medication, which could be the wrong dose, wrong medication, or wrong patient. It can also occur when the intent is unknown or malicious, such as taking a substance to harm oneself or being intentionally harmed by another. Accidental ingestion of a toxic substance is also classified as poisoning. The ICD-10-CM classification also details drug toxicity.

ICD-10-CM provides a “Table of Drugs and Chemicals” to identify codes for poisoning, adverse effects, and underdosing. Coders must refer to this table and then verify the code in the Tabular List. For pregnant patients, a code from subcategory O9A.2 (Injury, poisoning, and certain other consequences of external causes complicating pregnancy) is sequenced first, followed by the specific injury or poisoning code. If two or more drugs are taken, each should be coded individually unless a combination code exists.

IV. ICD-10-CM Z Codes for Medications

Z codes (Factors Influencing Health Status and Contact with Health Services) are used across all sections of the ICD-10-CM code book to provide easy reference for various situations, including medication use.

• Long-Term Drug Therapy (Z79): A code from Z79 is assigned if a patient is receiving medication for an extended period, either as a prophylactic measure (e.g., prevention of deep vein thrombosis) or for treatment of a chronic condition (e.g., arthritis, cancer).
• Exclusions: Z79 codes are not assigned for medications given for a brief period to treat an acute illness or injury (e.g., a course of antibiotics for acute bronchitis).
• Allergy Status (Z88): Codes from Z88 are used to indicate allergy status to drugs, medicaments, and biological substances. For instance, Z88.0 for penicillin allergy or Z88.9 for unspecified drug allergy.

V. Specific Drug Classes

A. Antimicrobial Drugs

• Antibiotics: Destroy or inhibit bacterial growth but are not effective against viral infections. They are categorized by chemical composition and mechanism, such as penicillins, cephalosporins, and tetracyclines. Broad-spectrum antibiotics work against many bacteria, while narrow-spectrum target specific types.
• Antifungals: Inhibit or kill fungal growth.
• Antivirals: Inhibit viral growth. Acyclovir is an example of an antiviral.
• Antiretrovirals: Treat infections caused by retroviruses.
• Antiprotozoals: Inhibit protozoal infections.
• Antituberculars: Suppress mycobacterium causing tuberculosis.
• New Technologies: Codes for new anti-infectives like Emapalumab-lzsg Anti-IFNy Monoclonal Antibody and Tarlatamab-dlle Antineoplastic are being added, particularly in the New Technology section for Introduction into central or peripheral veins.

B. Cardiovascular System Drugs These drugs treat a variety of heart and blood vessel disorders.

• Antianginals: Used for chest pains (angina). Nitrates (e.g., nitroglycerin) cause vasodilation, while beta blockers (e.g., metoprolol) reduce heart work, and calcium channel blockers (e.g., verapamil, amlodipine, diltiazem) treat chronic stable angina.
• Antihypertensives: Lower blood pressure (e.g., Tenormin, Zestril). Beta-adrenoreceptor antagonists (beta-blockers) are an example.
• Vasodilators: Dilate the vascular system (e.g., nitro patches/pills).
• Diuretics: Reduce fluid from the body.
• Vasoconstrictors: Cause constriction of blood vessels.
• Anticoagulants: Thin the blood, treating or preventing thrombosis (blood clots) and embolism (traveling blood clots). Examples include Coumadin, warfarin, and heparin, used for conditions like atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE).
• ACE Inhibitors: Affect heart rhythm.

C. Endocrine, Nutritional, and Metabolic System Drugs This is a vast system with many drug classes.

• Corticosteroids: Related to natural hormones, primarily treat inflammatory conditions and are used as replacement therapy for conditions like Addison’s disease.
• Diabetes Mellitus Drugs: Include insulin (Z79.4), injectable non-insulin antidiabetic drugs (Z79.85), and oral antidiabetic/hypoglycemic drugs (Z79.84).
• Lipid Lowering Drugs: Manage cholesterol.
• Hypothyroidism/Hyperthyroidism Drugs: Address thyroid hormone imbalances.

D. Mental, Behavioral, and Neurodevelopmental Disorder Drugs This category includes drugs for conditions like substance abuse and various mental disorders.

• Benzodiazepines: Such as diazepam (Valium) or chlordiazepoxide (Librium), used to reduce anxiety, particularly in alcohol withdrawal.
• Antiseizure Medications: Phenytoin (Dilantin), carbamazepine (Tegretol), and divalproex sodium (Depakote) can treat or prevent seizures.
• Muscle Relaxants: Such as diazepam (Valium), metaxalone (Skelaxin), and carisoprodol (Soma), relieve muscle spasms and ease limb movement in neurological disorders.
• Psychoactive Substances: The F10-F19 categories cover mental and behavioral disorders due to psychoactive substance abuse, dependence, and use, including alcohol, opioids, cannabis, hallucinogens, inhalants, and sedatives/hypnotics/anxiolytics.
  • Substance Abuse Treatment (Section H in PCS) includes root types such as Detoxification Services, Individual/Group Counseling, Individual Psychotherapy, Family Counseling, Medication Management, and Pharmacotherapy. Examples of pharmacotherapy include Nicotine Replacement, Methadone Maintenance, Antabuse, Naltrexone, and Naloxone.
  • Mental Health (Section G in PCS) includes Electroconvulsive Therapy (ECT), Hypnosis, Narcosynthesis, Group Psychotherapy, and Light Therapy. Narcosynthesis involves administration of intravenous barbiturates.

E. Neoplasm/Cancer Treatment Drugs Treatments for neoplasms (cancers) often involve chemotherapy, immunotherapy, and radiation therapy.

• Antineoplastics: Drugs used to combat cancer. Examples include Adriamycin, Ara-C, Doxorubicin, and Streptozocin.
• Immunosuppressants: Medications used in various cancer treatments and organ transplants.
• Monoclonal Antibodies: A specific type of antineoplastic or immunotherapeutic agent. For example, Tarlatamab-dlle Antineoplastic is a new substance.

F. Pain Management Drugs

• Analgesics: Relieve pain by blocking or interfering with pain signals. They can be opioids (e.g., hydromorphone HCI, oxycodone, tramadol) for moderate to severe pain, or non-opioids.
• Anesthetics: Produce analgesia (pain relief) or anesthesia (loss of consciousness/sensation). Local anesthetics (e.g., bupivacaine, lidocaine/Xylocaine) block nerve impulses. New medications like ZYNRELEF® (bupivacaine and meloxicam) are designed for postsurgical analgesia.

G. Respiratory System Drugs These target conditions affecting the respiratory tract.

• Bronchodilators: Open up bronchial passages (e.g., for asthma, COPD, emphysema).
• Sympathomimetics, Anticholinergics, Xanthines: Other specific medication classes for respiratory conditions.

VI. Other Important Drug-Related Conditions

• Drug-Induced Conditions: Drugs can cause various adverse conditions, such as drug or chemical-induced diabetes mellitus (E09.-), drug-induced dyskinesia or dystonia (G24.01, G24.02, G24.09), and osteonecrosis due to drugs (M87.1-).
• Neonatal Conditions: Newborns can be affected by maternal use of sedative-hypnotics (P04.17), other medications (P04.18), or alcohol (P04.3). Withdrawal symptoms from therapeutic drug use in newborns are also coded (P96.2).

VII. HCPCS Level II Codes for Drugs

The Healthcare Common Procedure Coding System (HCPCS) Level II codes are used to identify drugs and biologicals. CMS assigns dose descriptors in the smallest billable units to accommodate various doses and facilitate billing, often using generic or chemical names. Brand names are used to distinguish products with the same generic name if there are multiple on the market. Modifiers like JW and JZ are used to report unused and discarded amounts of drugs from single-dose containers.

Understanding these drug classes and their associated coding guidelines is vital for medical coders to accurately abstract patient records and assign appropriate ICD-10-CM and ICD-10-PCS codes, impacting reimbursement and quality measures.